The Journal of Experimental Medicine
Cytokines Montreal 2008
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 9 June 2003 doi:10.1084/jem.20022078
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erridge, C.
Right arrow Articles by Poxton, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erridge, C.
Right arrow Articles by Poxton, I. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Rockefeller University Press, 0022-1007/2003/6/1787 $5.00
The Journal of Experimental Medicine, Volume 197, Number 12, 1787-1791


Brief Definitive Report

Monocytes Heterozygous for the Asp299Gly and Thr399Ile Mutations in the Toll-like Receptor 4 Gene Show No Deficit in Lipopolysaccharide Signalling

Clett Erridge, John Stewart and Ian R. Poxton

Department of Medical Microbiology, University of Edinburgh Medical School, Edinburgh, EH8 9AG Scotland, United Kingdom

Address correspondence to I.R. Poxton, Medical Microbiology, University of Edinburgh Medical School, Teviot Place, Edinburgh, EH8 9AG Scotland, UK. Phone: 44-131-650-3128; Fax: 44-131-650-3128; E-mail: i.r.poxton{at}ed.ac.uk

Toll-like receptor 4 (TLR4)-mediated recognition of lipopolysaccharide (LPS) is required for efficient recognition of Gram-negative bacterial infections. Two commonly occurring mutations in the human TLR4 gene (Asp299Gly and Thr399Ile) have recently been shown to be associated with blunted physiological responses to inhaled LPS, and with increased risk of Gram-negative bacteraemia in sepsis patients and reduced risk of atherosclerosis in an Italian population. Here we show that monocytes from individuals heterozygous for both mutations in the TLR4 gene exhibit no deficit in recognition of LPS of Escherichia coli, Neisseria meningitidis, Bacteroides fragilis, Yersinia pestis, Chlamydia trachomatis, Porphyromonas gingivalis, or Pseudomonas aeruginosa. We propose that the relatively high frequency of these mutations in the Caucasian population may reflect modified responses of carriers to alternative TLR4 agonists.

Key Words: lipopolysaccharides • Toll-like receptor 4 • single nucleotide polymorphism • monocytes • innate immunity


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS